NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Mukesh Ambani
    WhatsApp
    Reliance Jio
    OPPO
    Vivo
    Sensex
    Bitcoin
    NewsBytes
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / Business News / Pfizer acquires Seagen for $43 billion to improve cancer treatments
    Business

    Pfizer acquires Seagen for $43 billion to improve cancer treatments

    Pfizer acquires Seagen for $43 billion to improve cancer treatments
    Written by Sanjana Shankar
    Mar 13, 2023, 08:19 pm 3 min read
    Pfizer acquires Seagen for $43 billion to improve cancer treatments
    Seagen specializes in antibody-drug conjugate (ADC) technology for cancer therapy

    Pfizer has acquired Seagen, a Washington-based biotechnology company, for approximately $43 billion, in an attempt to expand its reach in cancer treatment. The pharmaceutical company is reported to have paid $229 per share. Seagen is expected to generate a revenue of $2.2 billion in 2023 with 12% year-over-year growth from its four in-line medicines, royalties, and collaboration and license agreements.

    Why does this story matter?

    • Pfizer is one of the leading pharma companies in cancer treatments. It logged about $100 billion in total revenue last year, a major part of which came in through the COVID-19 vaccine as well as treatment.
    • With the latest acquisition, the company is all set to expand its portfolio of cancer-related treatments in the coming years.

    Seagen specializes in antibody-drug conjugate (ADC)

    Seagen, known as Seattle Genetics until 2020, specializes in antibody-drug conjugate (ADC) technology, designed as targeted therapy for the treatment of cancers. Four of the 12 total FDA-approved and marketed ADCs rely on Seagen's technology. With the latest acquisition of Seagen, Pfizer believes the brand could contribute more than $10 billion in risk-adjusted revenues in 2030, with potential significant growth after 2030.

    A look at Seagen's performance in 2022

    One of Seagen's best-selling drugs is Adcetris which is used to treat lymph system cancers. The firm recorded $839 million in sales in 2022, 19% more than the previous year. The company also saw sales rise by 33% to $451 million last year for Padcev, which treats urothelial cancer. It has also partnered with Pfizer's Array BioPharma to develop the breast cancer treatment Tukysa.

    The acquisition would help "Pfizer's near- and long-term financial goals"

    "Together, Pfizer and Seagen seek to accelerate the next generation of cancer breakthroughs and bring new solutions to patients by combining the power of Seagen's antibody-drug conjugate (ADC) technology with the scale and strength of Pfizer's capabilities and expertise," said Dr. Albert Bourla, Chairman of Pfizer. Bourla added that this acquisition would "contribute meaningfully to the achievement of Pfizer's near- and long-term financial goals."

    Pfizer Oncology has 24 approved innovative cancer medicines

    Pfizer Oncology has 24 approved innovative cancer medicines, including best-selling treatments for metastatic breast cancer. Through its cancer-related medicines, it generated about $12.1 billion in 2022. Earlier this year, Bourla said that the company is planning on buying products that could increase revenue by $25 billion by 2030. The company is expected to launch 19 new products over the next year and a half.

    The deal will be closed around late 2023

    Both Pfizer and Seagen expect to close the deal later this year or early 2024, once the required regulatory approvals are obtained. To finance the deal, Pfizer intends to raise $31 billion through debt and the remaining from a combination of short-term financing and cash.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Latest
    Pfizer
    Cancer

    Latest

    How to redeem Free Fire MAX codes for March 25 Garena Free Fire MAX
    International Waffle Day 2023: 5 savory waffle recipes to try Food
    Women's Boxing World Championships: Nikhat Zareen eyes this record Boxing Federation of India
    #NewsBytesExplainer: Exploring chamber films—meaning, characteristics, well-known examples Bollywood

    Pfizer

    Pfizer, BioNTech begin clinical trial for Omicron-specific vaccine BioNTech
    'Cautious optimism' after initial Omicron studies; here's what we know World Health Organization
    COVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective Serum Institute of India
    COVID-19: India reports 10K+ infections; 301 more deaths Coronavirus

    Cancer

    Navjot Singh Sidhu's wife suffering from cancer, pens emotional note Navjot Singh Sidhu
    Pleased to be alive: Actor Sam Neill on cancer battle Hollywood
    Joe Biden had cancerous skin lesion removed successfully in February Joe Biden
    Scientists find 'Bond villain' DNA that could revolutionize cancer treatment Research

    Love Business News?

    Subscribe to stay updated.

    Business Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023